Key Facts

In the United States

• Location: Swiftwater, PA
• Revenue: $2.64 billion in 2011.
• Employees: 3,000 employees

A global company:

• Headquarters: Lyon, France
• Revenue: €3,897 million in 2012 (growth of 5.7% compared with 2011 at constant exchange rates)
• Nearly 13,000 employees worldwide
• More than 50% of staff devoted to industrial operations
• 15 Production and/or R&D sites - 13 operational:
  • ​Marcy l'Etoile and Val de Reuil (FRANCE)
  • Swiftwater (Pennsylvania)
  • Cambridge and Canton (Massachusetts)
  • Orlando (Florida)
  • Rockville (Maryland) (USA)
  • Toronto (CANADA)
  • Pilar (ARGENTINA)
  • Shenzhen (CHINA)
  • Hyderabad (INDIA)
  • Ocoyoacac (MEXICO)
  • Chachoengsao (THAILAND)
• 2 new facilities under construction:
  • ​Neuville (FRANCE)
  • Shenzhen (CHINA)

Investment in research and production capacity:

• More than one billion doses of vaccines produced yearly to immunize more than 500 million people in the world
• Largest product range available, against 20 infectious diseases
• More than €1 million invested every day in R&D
• Nearly €2 billion invested in the last 5 years in production infrastructures.